Clinical trial
Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to…
NCT00006127 · Dana-Farber Cancer Institute, Other · Unknown status
Key facts
| NCT number | NCT00006127 |
|---|---|
| Title | Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Fanconi's Anemia |
| Intervention type | Drug |
| Interventions | amifostine |
| Enrollment | 21 |
| Start date | Apr 1, 2000 |
| First posted | Aug 4, 2000 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: